$11.84
00.00%
Last update: 4:00 PM
15 minutes delayed
Comments
Loading...
Astria Therapeutics
ATXSNASDAQ
Astria Therapeutics (NASDAQ:ATXS) Stock, Earnings Estimates, EPS, And Revenue
Astria Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of Astria Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATXS | Astria Therapeutics | -$0.45 | -$0.38 | — | — | $0.00 | — | — | — | 08/05/2024 | Get Alert |
| ATXS | Astria Therapeutics | -$0.40 | -$0.35 | -$0.38 | -8.57% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| ATXS | Astria Therapeutics | -$0.72 | -$0.78 | -$0.86 | -10.26% | $0.00 | — | $0.00 | — | 03/04/2024 | Get Alert |
| ATXS | Astria Therapeutics | -$0.87 | -$0.49 | -$0.63 | -28.57% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| ATXS | Astria Therapeutics | -$0.86 | -$0.49 | -$0.45 | 8.16% | $0.00 | — | $0.00 | — | 08/07/2023 | Get Alert |
| ATXS | Astria Therapeutics | -$1.18 | -$0.55 | -$0.40 | 27.27% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| ATXS | Astria Therapeutics | -$0.73 | -$0.71 | -$0.72 | -1.41% | $0.00 | — | $0.00 | — | 03/22/2023 | Get Alert |
| ATXS | Astria Therapeutics | -$0.61 | -$0.92 | -$0.87 | 5.43% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| ATXS | Astria Therapeutics | -$0.89 | -$1.01 | -$0.86 | 14.85% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| ATXS | Astria Therapeutics | -$0.24 | — | -$1.18 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| ATXS | Astria Therapeutics | -$0.45 | -$0.66 | -$0.73 | -10.61% | $0.00 | — | $0.00 | — | 03/10/2022 | Get Alert |
| ATXS | Astria Therapeutics | -$0.56 | -$0.77 | -$0.61 | 20.78% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.30 | -$0.89 | -196.67% | — | — | $0.00 | — | 08/09/2021 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.15 | -$0.24 | -60.00% | — | — | $0.00 | — | 05/13/2021 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.45 | -$0.45 | 0.00% | — | — | $0.00 | — | 03/11/2021 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.51 | -$0.56 | -9.80% | — | — | $0.00 | — | 11/12/2020 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.45 | -$0.53 | -17.78% | — | — | $0.00 | — | 08/10/2020 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.41 | -$0.50 | -21.95% | — | — | $0.00 | — | 05/12/2020 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.61 | -$0.55 | 9.84% | — | — | $0.00 | — | 03/10/2020 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.64 | -$0.56 | 12.50% | — | — | $0.00 | — | 11/07/2019 | Get Alert |
| ATXS | Astria Therapeutics | — | -$0.61 | -$0.62 | -1.64% | — | — | $0.00 | — | 08/08/2019 | Get Alert |
Astria Therapeutics (ATXS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.38 | $-0.35 | -8.57 % |
| Dec 2023 | 2024-03-04 | $-0.86 | $-0.78 | -10.3 % |
| Sep 2023 | 2023-11-13 | $-0.63 | $-0.49 | -28.6 % |
| Jun 2023 | 2023-08-07 | $-0.45 | $-0.49 | 8.16 % |
Astria Therapeutics (ATXS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Astria Therapeutics (NASDAQ:ATXS) reporting earnings?
Astria Therapeutics (ATXS) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Astria Therapeutics (NASDAQ:ATXS)?
The Actual EPS was $-0.38, which missed the estimate of $-0.35.
What were Astria Therapeutics’s (NASDAQ:ATXS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.